Sunday, May 16, 2010


CardioDex is a privately owned company engaged in the development, manufacturing, and marketing of devices for arterial access site closure, following catheterization procedures.

CardioDex has developed state-of-the-art disposable devices; EpicloseTM and EpicloseTM Plus that do not use any glue, collagen, suturing or other foreign materials thus no residual material is deposited in the patient’s body.
CardioDex's products expedite arterial closure through hemostasis. The process relies on familiar balloon inflation/deflation techniques, which apply selective pressure precisely over the puncture site. The products do not require exchange of the introducer sheath.
CardioDex's products address both the diagnostic and therapeutic markets.

No comments: